Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma

Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma

Abstract Background Tumor regression grade (TRG) is a measure of histopathological response to neoadjuvant therapy (NAT). Post‐therapy lymph node (ypN) metastasis was reported as a prognostic factor. However, the evaluation of the treatment effectiveness of NAT has not been well studied. Here, we ex...

Full description

Bibliographic Details
Main Authors: Hongyan Yin, Qian Yao, Yi Xie, Dongfeng Niu, Wenya Jiang, Huiying Cao, Xujiao Feng, Yanyan Li, Yilin Li, Xiaotian Zhang, Lin Shen, Yang Chen
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Cancer Medicine
Subjects:
gastroesophageal junction and gastric carcinoma
immunotherapy
lymph node status
neoadjuvant therapy
tumor regression grade
Online Access:https://doi.org/10.1002/cam4.6597

Internet

https://doi.org/10.1002/cam4.6597

Similar Items